Dihydrolipoamide Dehydrogenase (DLD) (Middle Region) Peptide
-
- Target See all DLD products
- DLD (Dihydrolipoamide Dehydrogenase (DLD))
- Protein Region
- Middle Region
- Origin
- Human
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-DLD antibody (Catalog #: ARP58455_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DLD (Dihydrolipoamide Dehydrogenase (DLD))
- Synonyms
- DLDD Peptide, DLDH Peptide, E3 Peptide, GCSL Peptide, LAD Peptide, PHE3 Peptide, AI315664 Peptide, AI746344 Peptide, wu:fb24b05 Peptide, DLD Peptide, DDBDRAFT_0183800 Peptide, DDBDRAFT_0216232 Peptide, DDB_0183800 Peptide, DDB_0216232 Peptide, sc:d0402 Peptide, dihydrolipoamide dehydrogenase Peptide, dihydrolipoyl dehydrogenase Peptide, deltaD Peptide, DLD Peptide, Dld Peptide, dldh Peptide, AT4G16155 Peptide, CND05840 Peptide, bfmBC Peptide, GCSL Peptide, LACBIDRAFT_182385 Peptide, UREG_06178 Peptide, lpd Peptide, TAGG_RS02070 Peptide, Arnit_2606 Peptide, Mesil_1945 Peptide, Trad_2118 Peptide, Acear_0640 Peptide, Fbal_0372 Peptide, Ilyop_1890 Peptide, Ftrac_1733 Peptide, Ocepr_1753 Peptide, Intca_2017 Peptide, Deima_0504 Peptide, dld Peptide
- Background
-
DLD is the L protein of the mitochondrial glycine cleavage system. The L protein, also named dihydrolipoamide dehydrogenase, is also a component of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acide dehydrogenase complex. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency.This gene encodes the L protein of the mitochondrial glycine cleavage system. The L protein, also named dihydrolipoamide dehydrogenase, is also a component of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acide dehydrogenase complex. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: DLDH, E3, GCSL, LAD, PHE3
Protein Interaction Partner: DLD,OGDH,PDHX,SLC2A4,OGDH
Protein Size: 509 - Molecular Weight
- 56 kDa
- Gene ID
- 1738
- NCBI Accession
- NM_000108, NP_000099
- UniProt
- B2R5X0
-